[Further clinical experiences with maprotiline in endogeneous depressions].
作者信息
Náhunek K, Svestka J, Rysánek R, Cesková E
出版信息
Act Nerv Super (Praha). 1982 May;24(2):81-7.
PMID:7048835
Abstract
摘要
相似文献
1
[Further clinical experiences with maprotiline in endogeneous depressions].
Act Nerv Super (Praha). 1982 May;24(2):81-7.
2
Clinical experience with maprotiline.麦普替林的临床经验。
Act Nerv Super (Praha). 1982 May;24(2):93-8.
3
Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Int Clin Psychopharmacol. 1989 Jan;4 Suppl 1:47-50.
4
[Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
Act Nerv Super (Praha). 1982 May;24(2):101-5.
5
Maprotiline versus imipramine and placebo in neurotic depression.马普替林与丙咪嗪及安慰剂治疗神经症性抑郁症的对照研究
J Clin Psychiatry. 1981 Apr;42(4):138-41.
6
Therapeutic superiority of maprotiline versus doxepin in geriatric depression.麦普替林与多塞平治疗老年抑郁症的疗效比较
J Clin Psychiatry. 1983 Dec;44(12):449-53.
7
[Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
Act Nerv Super (Praha). 1982 May;24(2):88-9.
8
[The effect of maprotiline on target symptoms of depressive states].
Act Nerv Super (Praha). 1982 May;24(2):99-100.
9
[Use of maprotiline in the treatment of depressions in predominantly geriatric patients. Preliminary report].[麦普替林在老年为主的抑郁症患者治疗中的应用。初步报告]
Wien Med Wochenschr. 1976 Dec 3;126(49-50):702-5.
10
[The Eppendorf Mood and Motivation Scale as assessment procedure in the clinical evaluation of an antidepressive agent].
Fortschr Med. 1982 Dec 2;100(45):2111-7.
Zotero 插件